AtriCure (ATRC) Retained Earnings (2010 - 2026)
AtriCure's (ATRC) quarterly Retained Earnings came in at -$404.1 million in Q2 2026, up 2.54% year-over-year from -$394.1 million in Q2 2025, and up 2.17% quarter-over-quarter from -$413.1 million in Q1 2026.
Analysis
AtriCure (ATRC) Retained Earnings (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Retained Earnings for 17 consecutive years, with -$404.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings rose 2.54% year-over-year to -$404.1 million in Q2 2026; TTM through Jun 2026 was -$404.1 million, a 2.54% increase from a year earlier, with the FY2025 full-year figure at -$413.2 million, down 2.85% from the prior year.
- Retained Earnings was -$404.1 million for Q2 2026 at AtriCure, up from -$413.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$3.5 million in Q1 2022 and troughed at -$415.0 million in Q3 2025.
- A 5-year average of -$352.4 million and a median of -$374.3 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 356425.29% in 2022 and rose 2.54% in 2026, its largest moves.
- Over 5 years, Retained Earnings stood at -$326.6 million in 2022, then dropped by 9.32% to -$357.1 million in 2023, then retreated by 12.52% to -$401.8 million in 2024, then retreated by 2.85% to -$413.2 million in 2025, then advanced by 2.19% to -$404.1 million in 2026.
- The last three Retained Earnings figures came in at -$404.1 million (Q2 2026), -$413.1 million (Q1 2026), and -$413.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.15 Bn |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | -404.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -404.14 Mn |
| Mar 31, 2026 | -413.10 Mn |
| Dec 31, 2025 | -413.20 Mn |
| Sep 30, 2025 | -414.96 Mn |
| Jun 30, 2025 | -414.69 Mn |
| Mar 31, 2025 | -408.50 Mn |
| Dec 31, 2024 | -401.76 Mn |
| Sep 30, 2024 | -386.19 Mn |
| Jun 30, 2024 | -378.33 Mn |
| Mar 31, 2024 | -370.33 Mn |
| Dec 31, 2023 | -357.06 Mn |
| Sep 30, 2023 | -347.27 Mn |
| Jun 30, 2023 | -338.21 Mn |
| Mar 31, 2023 | -333.10 Mn |
| Dec 31, 2022 | -326.62 Mn |
| Sep 30, 2022 | -322.45 Mn |
| Jun 30, 2022 | -310.18 Mn |
| Mar 31, 2022 | -3.47 Mn |
| Dec 31, 2021 | -280.15 Mn |
| Sep 30, 2021 | -266.41 Mn |